baber/WOPTO huggingface dataset:
Patent NZ-202615-A (NZ)
Title: Producing liquid-solid metal alloy
Inventor: BUSK R S
IPC: C22C1/00
Filed: 1982-11-25
Abstract: A process for producing a liquid-solid composition comprising heating a liquefiable material sufficiently to form a liquid phase with solid dendritic particles therein without completely liquefying the material and subjecting said liquid-solid material to a shearing action sufficient to break at least a portion of the dendritic structures. The process includes injection molding, forging or die casting the material produced by the process.
Patent NZ-207628-A (NZ)
Title: Gamma radiation scatter detection: plural detectors 'see' at different depths
Inventor: MOLBERT J L
IPC: G01N23/203
Filed: 1984-03-26
Abstract: A radiation scatter gauge (10) comprises a radiation source (20) and multiple detectors (22,24,26) for developing separate and independent sets of data from which multiple physical characteristics of a thin material (T) and underlying substrate (B) may be determined. The apparatus and method of the invention are directed to determining characteristics of resurfaced pavement by nondestructive testing. More particularly,the density and thickness of a thin asphalt overlay (t) and the density of the underlying pavement (B) may be determined.
Patent NZ-213756-A (NZ)
Title: Anti-inflammatory compositions containing indomethacin or piroxicam and a 2-guanidino-4-(4-imidazolyl)thiazole
Inventor: LAMATTINA J L
IPC: A61K31/425
Filed: 1985-10-09
Abstract: An improved antiinflammatory composition and method of treating inflammation which employs a combination of an antiinflammatory agent (e.g. indomethacin or an oxicam) with a histamine-H<sub>2</sub> antagonist selected from the group consisting of 2-guanidino-4-(4-imidazolyl)thiazole, 2-guanidino-4-(2-methyl-4-imidazolyl)thiazofe, 2-(N-benzyl-N'-guanidino)-4-(2--methyl-4-imidazolyl)thiazole, 2-(N-pentyl-N'-guanidino)-4-(2--methyl-4-imidazolyl)thiazole and 2-guanidino-4-[2-hexyt- aminol-4-imidazolyl]thiazole.
Patent NZ-216199-A (NZ)
Title: Spin-welding of plastics: programmed logic controller operates low inertia dc servo motor
Inventor: NUTTALL K E
IPC: B29C65/06
Filed: 1986-05-16
Abstract: Apparatus for spin-welding comprises a spin welding machine having a spin welding head (16), a ram assembly (15), and a feed mechanism (12); the ram assembly is driven from a shaft (8) and the feed mechanism comprises a rotating turret mounted on a shaft (13) which is driven from the shaft (8) via a Geneva mechanism (14). The spin welding head (16) is driven by a low inertia DC servo motor (17) operated by a programmable logic controller and timed from a switch unit (18) driven off the shaft (8).
Patent NZ-220645-A (NZ)
Title: Modified varicella-zoster virus and its cultivation
Inventor: ELLIS R W
IPC: A61K39/295
Filed: 1987-06-10
Abstract: A vaccine strain of varicella-zoster virus (VZV), tested in clinical trials, is capable of preventing chickenpox in children. This virus has been modified by the introduction into its genome of heterologous DNA which encodes an immunogenic polypeptide of another human pathogen. This heterologous polypeptide is expressed in cells infected by the recombinant virus. Such recombinant VZV is useful as a vaccine for chickenpox as well as for heterologous pathogens.
Patent NZ-231632-A (NZ)
Title: 1,2,4-triazoles and bicyclo-analogues thereof
Inventor: BAUS ULF
IPC: C07D249/12
Filed: 1989-12-05
Abstract: 1-Hydroxy-1,2,4-triazoles of the general formula I 
<IMAGE>
 in which
 R<1> and R<2> independently of one another denote hydrogen, alkyl, halogen, optionally substituted aryl or together denote an alkylene chain,
 and the process for their preparation.
Patent NZ-248922-A (NZ)
Title: Dosing syringe; end of dose indicator produces sound when complete dose has been administered
Inventor: HARRIS DALE CARVIN
IPC: A61M5/315
Filed: 1993-10-12
Abstract: This invention provides an improvement in injection syringes by providing for a sound as an indication that the complete dose has been administered. The end of dose indicator (20) of this invention is operatively associated with the dose knob (15) of a injection syringe (1) which is raised to set the dose and pushed to inject the dose. The improvement comprises a means for producing a sound which is set to produce a sound when the dose knob (15) is pushed to the end of the dose and also includes a means (24) for resetting the above means when pressure is released from the dose knob (15) after the dose is injected. <IMAGE>
Patent NZ-256787-A (NZ)
Title: Oligonucleotides with a conserved g4 core sequence
Inventor: HANECAK RONNIE C
IPC: C12Q1/70
Filed: 1995-03-27
Abstract: Modified oligonucleotides having a conserved G4 sequence and a sufficient number of flanking nucleotides to significantly inhibit the activity of a virus such as HSV-1 or phospholipase A2 or to modulate the telomere length of a chromosome are provided. G4 quartet oligonucleotide structures are also provided. Methods of prophylaxis, diagnostics and therapeutics for viral-associated diseases and diseases associated with elevated levels of phospholipase A2 are also provided. Methods of modulating telomere length of a chromosome are also provided; modulation of telomere length is believed to play a role in the aging process of a cell and in control of malignant cell growth.
Patent NZ-260164-A (NZ)
Title: Substituted pyridopyrimidinone derivatives, preparation and pharmaceutical compositions thereof
Inventor: ELLINGBOE JOHN WATSON
IPC: A61P43/00
Filed: 1994-03-23
Abstract: This invention relates to intermediates useful in the production of substituted pyridopyrimidinones of general formula (I): <CHEM>  wherein     n is 0 to 3; R<1> and R<2> are, independently, H, C1-C6alkyl, hydroxy(C1-C6alkyl), formyl, carbonyl(C1-C6alkyl), carboxy, or carboxy(C1-C6alkyl);   R<3> and R<4> are, independently, H, C1-C6alkyl, or hydroxy; R<3a> and R<4a> are H, or one of -CR<3>R<3a> and -CR<4>R<4a> is a carbonyl group; with the proviso that at least one of the groups R<1> and R<2> must be hydroxy(C1-C6alkyl), formyl, carbonyl(C1-C6alkyl), carboxy, or carboxy(C1-C6alkyl); or one of R<3> and R<4> must be hydroxy; or one of -CR<3>R<3a> and -CR<4>R<4a> must be a carbonyl group; ;   Ar<1> is <CHEM>     wherein W is H, C1-C6alkyl, halogen, hydroxy, or C1-C6alkoxy;   Ar<2> is <CHEM>     wherein X is <CHEM> wherein R<5> is H, CH3, tert-butyl, tri-n-butylstannyl, or triphenylmethyl; or a tautomer of said compound,  or a pharmaceutically acceptable salt of said compound or tautomer. The compounds of Formula I are useful for treating hypertension and congestive heart failure. Also disclosed are pharmaceutical compositions containing compounds of Formula I and a pharmaceutically acceptable carrier and methods for production of the compounds of Formula I. Intermediates for making the pharmaceutical useful compounds are also enclosed.
Patent NZ-330701-A (NZ)
Title: Winch having portions with two or more different diameters
Inventor: ATFIELD PHILIP JOHN
IPC: B66D1/74
Filed: 1998-06-17
Abstract: winch 1 for hauling a line comprises a drum 4 rotatable about an axis of rotation which is for engaging the line.  Drum 4 comprises a first drum portion 9 having a diameter and a second drum portion 6 having a diameter smaller than the diameter of first drum portion 9 and a projection 8 projecting between them radially of the axis.  The line when on the drum is transferable past projection 8 from first drum portion 9 to second drum portion 6.  The drum portions have respectively different surface treatments.  The surface treatment of first drum portion 9 gives a less aggressive grip than that of second drum portion 6.
Patent NZ-334752-A (NZ)
Title: Beer foam reducing apparatus
Inventor: O'NEIL BRENDAN
IPC: B67D1/12
Filed: 1997-08-29
Abstract: A beer foam reducing apparatus (10) is disposed for placement into the beer delivery lines between a keg (12) and a beer serving spout (16) to prevent pressurized carbon dioxide from entering the delivery line between the apparatus (10) and the serving spout (16) when a keg (12) empties of beer.  The apparatus (10) comprises a base (20) with a shallow receptacle disposed to receive an inverted, clear plastic container (24) for sealed, threaded engagement.  The plastic container (24) is easily removed for cleaning or replacement and easily sealed for operation.  The apparatus (10) also comprises an inlet and outlet in the base, a float (144) disposed for releasably sealing the outlet of the base (20) when a keg (12) empties, and a flow control column (52) secured in the base (20) and extending upwards into the inverted container (24).
Patent NZ-334873-A (NZ)
Title: Waxy wheat starch types having waxy proteins in granule
Inventor: KEELING PETER L
IPC: C07K14/415
Filed: 1997-10-07
Abstract: Broadly, the present invention relates to mutating starch genes in polyploid cereal grains. Specifically, this invention concerns mutant wheat plants, mutant wheat grain and the starch therefrom.
Patent NZ-505495-A (NZ)
Title: Computer planning and analysis of flexible employee benefit schemes
Inventor: HYMAN ANDREW A
IPC: G06Q40/00
Filed: 2000-06-29
Abstract: A computerized technique is utilized to devise the financial aspects of a plan of benefits for a population of employees in accordance with a set of goals ranked by an employer of the employees, each benefit having a cost.  Having entered the cost variables for the benefits, the relationships between the benefits and the goals, and the priorities of the employer, an optimum solution of the cost variables in accordance with the ranked goals is derived.
Patent NZ-505876-A (NZ)
Title: Solid nanosphere composition and delivery of a coacervate polymeric cation (gelatine or chitosan) and a polyanion (nucleic acids)
Inventor: TRUONG VU
IPC: A61K47/48
Filed: 1999-01-15
Abstract: Coacervates of nucleic acids and a polycationic biopolymer are useful for delivery of genes encoding antigens to mammals. The expression of the antigens in the mammal induces an immune response to the antigen. Furthermore, encapsulation of either or both the antigen protein and a cytokine enhance the immune response. Selection of cytokines can be used to manipulate the type of immune response which is induced.
Patent NZ-507205-A (NZ)
Title: Apoprotein antigens encoded by the mhp3 gene fur use in vaccines to prevent diseases caused by infection with mycoplasma hyopneumoniae
Inventor: ROSEY EVERETT LEE
IPC: A61P31/04
Filed: 2000-09-28
Abstract: The mhp3 gene codes for a protein of Mycoplasma hyopneumoniae, which is a bacterial pathogen that causes enzootic mycoplasmal pneumonia in swine.  Nucleotides and proteins of the M. hyopneumoniae mhp3 gene and gene product are discussed.  Apportion antigens encoded by the mhp3 gene can be used in vaccines for the treatment and prevention of diseases in swine caused by M. hyopneumoniae infection.  Methods for the recombination production of apo-Mhp3 are also provided.
Patent NZ-512512-A (NZ)
Title: Improvements in or relating to control and/or monitoring systems
Inventor: BODY NICHOLAS BERNARD
IPC: E05B49/00
Filed: 2000-02-10
Abstract: An access control device including electronic identification means, the access control device characterised in that the access control device also includes an audio communication device wherein the electronic identification means and the audio communications device are configured to access the same communications systems wherein the communications device transmits in digitised format. There is also a claim for a method of installing a control / monitoring system.
Patent NZ-518491-A (NZ)
Title: Data address and payload conversion for transfer from first to second network for a display unit
Inventor: ALLAWAY ANDREW WAYNE
IPC: H04B7/185
Filed: 2000-08-10
Abstract: An interface (52) is provided between a satellite telephone system (4) and a cellular telephone system (5) for allowing calls to a user's cellular telephone to be diverted to a satellite telephone handset (25) when the user is unable to use his cellular telephone, for example when on board an aircraft (2) fitted with a satellite telephone system (20). The user inserts a card (which may be the SIM of his mobile phone, or a card compatible with existing satellite telephone equipment) into a suitable reader in the satellite telephone (20), which causes the satellite ground station's card verification system (42) to connect to a host cellular network (50). The host cellular network has an interface unit (52) which emulates the operation of a normal base station, so that the host cellular system (50) acts as if the mobile user's terminal is roaming on the host network, but is currently "busy". The interface (52) also resets the user's existing call diversion instructions so that when the host cellular system (5) receives a busy tone from the base station emulator (52), it routes calls to the directory number of the terminal (20). Data messages originally formatted for transmission over the cellular telecommunications network for generation of a display on a display unit of a cellular telephone, can instead be transmitted over the satellite network for display on the information and entertainment system of the aircraft by replacing the address information in the original data message by address information appropriate to the selected display unit to generate an amended data message. A new data message is created, addressed to the server of the information display system and having the amended data message as payload. The onboard server has means for converting the amended data message into control instructions suitable to display the information content of the data message on the information display unit identified in the amended data message.
Patent NZ-523659-A (NZ)
Title: Use of IL-8 receptor antagonists in the treatment of virus infections
Inventor: DILLON SUSAN B
IPC: A61K45/00
Filed: 2001-07-16
Abstract: The use of an IL-8 receptor antagonist for the preparation of a medicament for treating symptomology of the common cold as caused by a respiratory viral infection selected from the group consisting of human rhinovirus, other enterovirus, herpes virus, coronavirus, influenza virus, parainfluenza virus, repiratory syncytial virus, or adenovirus infection in a human in need thereof, is disclosed. The respiratory viral infection may exacerbate asthma, chronic bronchitis, chronic obstructive pulmonary disease, otitis media or sinusitis. The respiratory viral infection may be associated with a second bacterial infection, such as otitis media, sinusitis or pneumonia.
Patent NZ-525601-A (NZ)
Title: Method of locating a web page by utilising visual images relating to the web page
Inventor: LANGFORD RONALD N
IPC: G06F17/30
Filed: 2001-10-03
Abstract: This method for locating web-pages includes a user submitting a search request to a server-side application via a terminal; the server-side application searching a database in accordance with the submitted search request; and identified database entries being transmitted to the terminal as a search results list, each entry containing a hyperlink to a web-page; whereby, each entry of the search results list contains visual content, the visual content related to the web-page for which the entry contains a hyperlink, the user able to view the visual content without being required to activate the hyperlink to obtain the visual content. A method of assisting a user to be placed in contact with an organization, includes the user submitting a search request from a terminal, via a computer network, to a database server, the database server containing a database and a server-side application used as database searching software; the database searching software searching the database in accordance with the search request; identified database entries being transmitted to the terminal as a search results list, each entry of the search results list containing contact information for the organization; at least one entry of the search results list additionally containing visual content and/or audio content which relates to the organization.
Patent NZ-527047-A (NZ)
Title: Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
Inventor: PAGANO MICHELE
IPC: C12Q1/68
Filed: 2002-01-07
Abstract: The present invention relates to the discovery, identification and characterization of nucleotides that encode novel substrate-targeting subunits of ubiquitin ligases. The invention encompasses nucleotides encoding novel substrate-targeting subunits of ubiquitin ligases: FBP1, FBP2, FBP3, FBP4, FBP5, FBP6, FBP7, FBP8, FBP9, FBP10, FBP11,FBP12,FBP13,FBP14,FBP15,FBP16,FBP17,FBP18,F FBP19,FBP20,FBP21,FBP22,FBP23,FBP24, and FBP25, transgenic m ice, knock-out mice, host cell expression systems and proteins encoded by the nucleotides of the present invention. The present invention relates to screening assays that use the novel substrate-targeting subunits to identify potential therapeutic agents such as small molecules, compounds or derivatives and analogues of the novel ubiquitin ligases which modulates activity of the novel ubiquitin ligases for the treatment of proliferative and differentiative disorders, such as cancer, major opportunistic infections, immune disorders, certain cardiovascular diseases, and inflammatory disorders. The invention further encompasses therapeutic protocols and pharmaceutical compositions designed to target ubiquitin ligases and their substrates for the treatment of proliferative disorders.
Patent NZ-529874-A (NZ)
Title: Aromatic dicarboxylic acid derivatives useful as HDAC inhibitors
Inventor: LESER-REIFF ULRIKE
IPC: A61P43/00
Filed: 2002-06-13
Abstract: Aromatic hydroxamic acid (aromatic dicarboxylic acid) derivative compounds of formula (I), process of manufacturing these compounds and medicaments with HDAC inhibitor activity containing such compounds are disclosed, wherein A, R1 and R2 are as defined in the specification.
Patent NZ-531244-A (NZ)
Title: Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo [1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders
Inventor: GALLET THIERRY
IPC: A61P3/04
Filed: 2002-09-19
Abstract: Disclosed are pyrimidone compounds of formula (I), wherein: X is two hydrogens, a sulphur, an oxygen or an alkyl and a hydrogen, Y is a bond, an ethenylene, an ethynylene, an oxygen, a sulphur, sulfonyl, sulfoxide, carbonyl, an optionally substituted nitrogen, or an optionally substituted methylene group, R1 is an optionally substituted pyrmidine ring, and the remaining substituents are defined herein. The compounds are used for the manufacture of medicaments for the treatment of diseases caused by abnormal GSK3-beta or GSK3-beta and cdk5/p25 activity.
Patent NZ-533274-A (NZ)
Title: Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (PPAR)
Inventor: ALSTERMARK LINDSTEDT EVA-LOTTE
IPC: C07C231/12
Filed: 2002-12-18
Abstract: The present invention provides the S enantiomer of a compound of formula (I); wherein R1 represents 2,4-difluorophenyl or cyclohexyl as well as pharmaceutically acceptable salts, solvates, crystalline forms and in vivo cleavable esters thereof, to processes for preparing such compounds, to their the utility in treating clinical conditions including lipid disorders (dyslipidemias) whether or not associated with insulin resistance, and to pharmaceutical compositions containing them.
Patent NZ-534190-A (NZ)
Title: Divided dose therapies with vascular damaging activity
IPC: A61K33/243
Filed: 2001-03-27
Abstract: Use of a vascular damaging agent or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for administration in divided doses for use in the production of a vascular damaging effect in a warm-blooded animal such as a human. The vascular damaging agent may be ZD6126, or a pharmaceutically acceptable salt thereof.
Patent NZ-536651-A (NZ)
Title: Spray-drying device and feed means for this spray-drying device
Inventor: BOERSEN ANTONIUS CORNELIS
IPC: B01D1/20
Filed: 2003-04-24
Abstract: The invention provides a spray-drying device comprising a housing (1), a first feed means (2) with a first spray opening, for supplying a first substance, the first substance being a liquid which is sprayed in a cone (3; 3a, 3b) in a first outlet direction, a second feed means (4) for supplying a particle stream (5) in a second outlet direction, the first and second outlet directions including an angle alpha with respect to one another, and flow-control means for controlling the flow of the liquid and the particle stream, at least one out of the first (2) and second (4) feed means comprising angle- adjustment means (6, 9) for adjusting the angle alpha, and therefore the overlap and properties of particles or agglomerates formed. The invention also provides a feed means for feeding a material to a spray-drying device according to the invention.
Patent NZ-537923-A (NZ)
Title: Hard surface cleaners which provide improved fragrance retention properties to hard surfaces
Inventor: KLINKHAMMER MICHAEL E
IPC: C11D3/20
Filed: 2003-07-16
Abstract: Disclosed herein are hard surface cleaners which provide improved fragrance retention properties to the treated hard surface, and methods for using them. The cleaners include a fragrance, a carrier, and a surfactant mixture comprising an alkyl polyglycosides having the formula RO-Zn, wherein R is an alkyl group having 8 to 14 carbon atoms, Z is a glucose moiety, and n is a number having an average value of about 2.5 and an ethoxylated mixed C13 and C15 alcohol with from 3 to 10 ethylene oxide units, the surfactant mixture being from 0.5% w/v to 20% w/v of the cleaner. The cleaner may also contain water and a base.
Patent NZ-539255-A (NZ)
Title: Antigenic compositions and use thereof for immunisation of non-human mammals such as horses against Streptococcus equi
Inventor: GUSS BENGT
IPC: C07K16/12
Filed: 2003-10-10
Abstract: Disclosed is an antigenic composition comprising at least one antigen that comprises an antigenic epitope of the protein EAG and at least one antigenic epitope from a protein selected from FNZ, SFS, SEC and Scl and use thereof for immunization of non-human mammals against S. equi subsp. equi and/or subsp. Zooepidemicus. Also disclosed is a vaccine composition comprising the antigenic composition as immunizing component, in particular against strangles.
Patent NZ-539902-A (NZ)
Title: Large conductance calcium-activated K channel opener
Inventor: HOSAKA TOSHIHIRO
IPC: A61P13/00
Filed: 2003-10-15
Abstract: Disclosed are 5 membered heterocyclic compounds of the formula (I) wherein: ring A is represented by any one of the formulae shown; R1 is a substituted or unsubstituted aryl, a substituted or unsubstituted heterocycle or a substituted or unsubstituted heterocycle-substituted carbonyl; R2 is a substituted or unsubstituted alkyl; R3 is a substituted or unsubstituted aryl, substituted or unsubstituted heterocycle or a substituted or unsubstituted alkyl; and R4 is H or a substituted or unsubstituted alkyl. Compounds of the type disclosed are useful in the treatment of diseases where a large conductance calcium-activated K channel opening activity is efficacious.